What is the incidence of primary sinonasal lymphoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Incidence of Primary Sinonasal Lymphoma

Primary sinonasal lymphoma is a rare malignancy, accounting for approximately 1-2% of all lymphomas and representing about 1% of all head and neck cancers 1, 2.

Epidemiological Data

The incidence data from multiple studies consistently demonstrates the rarity of this entity:

  • Among all head and neck cancers: Primary sinonasal lymphoma comprises approximately 1% of all head and neck malignancies 1

  • Among all lymphomas: These tumors represent 1-2% of all lymphomas 2 and 1.5% of all non-Hodgkin lymphomas 3

  • Among extranodal lymphomas: They constitute 2.2% of extranodal lymphomas in white populations 3

  • Among sinonasal malignancies: Lymphoma is listed among the less common sinonasal malignancies, with squamous cell carcinoma being the most frequent 4

Clinical Context

In a large institutional series examining malignant immunoproliferative diseases, primary sinonasal and orbital NHL occurred with a frequency of 6% among all malignant immunoproliferative diseases 5. Another Japanese study found that among 96 newly diagnosed lymphoma patients, primary sinonasal lymphoma was identified in 6% of cases 6.

Key Demographics

  • Median age at diagnosis: 59-68 years 7, 8
  • Male predominance: Male-to-female ratio of approximately 1.35:1 7
  • Peak incidence: 60% of cases occur in the sixth to eighth decades of life 7

Most Common Histologic Subtype

Diffuse large B-cell lymphoma (DLBCL) is the predominant subtype, accounting for 30-46% of primary sinonasal lymphomas 5, 7, 8, followed by extranodal NK/T-cell lymphoma (17.9%) 8.

Important caveat: Geographic variation exists, with T-cell phenotypes being more common in South America and Asia, while B-cell predominance is observed in the United States 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.